Lung Metastases
34
9
11
13
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.9%
2 terminated out of 34 trials
86.7%
+0.2% vs benchmark
6%
2 trials in Phase 3/4
38%
5 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (34)
In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
Oxford Pleural Embolisation Trial
Shared Decision Making on Radiation Dose for Lung Malignancies
Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors
On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
Chemoembolization for Lung Tumors
Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis
Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung.
Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases
Surveillance AFter Extremity Tumor surgerY
Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.
Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma
Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis
AI Prediction Model and Risk Stratification for Lung Metastasis in Colorectal Cancer
Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative Radiotherapy
SBRT Dose Escalation for Reirradiation of Inoperable Lung Lesions